Loading clinical trials...
Loading clinical trials...
Dupilumab Therapy for Refractory Eosinophilic Gastrointestinal Disorders in Children
Conditions
Interventions
Dupilumab - Standard Dose
subcutaneous injection
Locations
1
China
201102
Shanghai, China
Start Date
January 1, 2025
Primary Completion Date
January 1, 2027
Completion Date
December 1, 2027
Last Updated
December 2, 2025
Lead Sponsor
Children's Hospital of Fudan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions